遗传变异支持氨酸在预防缺血性中风中的因果作用
Ernst Mayerhofer1,2,3, Livia Parodi1,2,3,4, Kaavya Narasimhalu1,2,3
1Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
概括
瓦尔酸盐的使用,由遗传反应预测,可能会降低缺血性中风风险. 这项研究提供了对酸的因果关系证据.
科学领域:
- 药物基因组学 药物基因组学
- 神经学 神经学
- 心血管研究研究心血管研究
背景情况:
- 瓦尔酸盐表现出抗动脉样硬化性质,这表明它有可能预防缺血性中风.
- 观察性研究将氨酸使用与降低中风风险联系起来,但根据指示混限制因果推断.
研究的目的:
- 使用孟德尔随机化研究影响氨酸发作反应和缺血性中风风险的遗传变异之间的因果关系.
- 为了确定对氨酸反应的遗传分数是否与缺血性中风发生率和复发有关.
主要方法:
- 从全基因组关联数据中获得了对氨酸反应的遗传分数.
- 测试了这种遗传分数与缺血性中风的关联,在英国生物银行和大众普利格姆生物银行的瓦尔酸盐用户中进行了测试.
- 采用了考克斯的比例危险模型,并根据相关的共变量进行了调整.
主要成果:
- 较高的氨酸反应遗传分数与血清氨酸水平的增加相关.
- 基因预测有利的氨酸反应与降低缺血性中风风险 (HR 0.73 per SD) 和复发性中风风险 (HR 0.53 per SD) 相关.
- 在氨酸非使用者中,遗传分数和缺血性中风之间没有观察到任何关联,这表明微小的质性.
结论:
- 基因预测对氨酸的有利发作反应与氨酸使用者的缺血性中风风险降低有因果关系.
- 酸在预防中风和治疗中风后方面可能具有双重益处.
- 需要进行进一步的临床试验,以确定最佳的患者群体,以预防基于酸的中风.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
346
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
346
Antiepileptic Drugs: GABAergic Pathway Potentiators
464
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
464
Antiepileptic Drugs: Glutamate Antagonists
424
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
424
Antiepileptic Drugs: Potassium Channel Activators
214
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
214
Regulation of Stroke Volume
3.3K
The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
3.3K
Mutation, Gene Flow, and Genetic Drift
58.6K
In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
58.6K


